A Cure for Cancer? How CAR-T Cell Therapy is Revolutionizing Oncology
CAR-T therapy has been hailed as a cure for cancer, but what really is this…
CAR-T therapy has been hailed as a cure for cancer, but what really is this…
Last month, the US firm bluebird bio abandoned the sale of its gene therapy Zynteglo…
The US company bluebird bio has launched the first gene therapy for the blood disorder…
The Danish big pharma Novo Nordisk has joined forces with the US gene therapy company…
Zynteglo, a gene therapy developed by the US company bluebird bio for the treatment of…
The US biotech company bluebird bio has obtained EU conditional market approval for a gene…
Bluebird bio has obtained results from two clinical studies showing its new gene therapy could eliminate…
TC Biopharm has scored a deal with bluebird bio for the development of the next…
Curious about which technologies have attracted the most cash in biotech finance this year? Here's a…
Juno’s JCAR015 study came to a halt for the second time this year after two…
UniQure from the Netherlands has promising results for its enzyme replacement therapy phase Ib/II trial…
The biggest biocluster of the World is still attractive. Munich-based Sirion Biotech decided to open…